Petros Pharmaceuticals Inc (PTPI)
NASDAQ
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -111.404 | -32.11 | -13.096 | -40.152 | -41.723 |
Return on Equity (%) | -810.849 | -161.535 | -33.904 | -76.705 | -96.021 |
Return on Invested Capital (%) | -355.222 | -237.031 | -72.501 | -30.866 | -58.878 |
Operating Margin (%) | -123.978 | -198.378 | -110.332 | -324.466 | -131.003 |
Net Profit Margin (%) | -208.712 | -215.357 | -115.056 | -334.413 | -237.272 |
Book Value Per Share | -8.964 | -1.513 | 0.496 | 0.215 | 1.655 |
Earnings Per Share | -9.465 | -2.121 | -0.434 | -0.968 | -6.516 |
Cash Per Share | 0.625 | 1.766 | 1.153 | 0.455 | 6.291 |
Working Capital Per Share | -8.447 | -1.647 | -0.021 | 0.367 | 4.537 |
Operating Profit Per Share | 2.373 | 0.568 | 0.3 | 0.342 | 1.977 |
EBIT Per Share | -9.653 | -2.268 | -0.434 | -0.968 | -3.85 |
EBITDA Per Share | -9.653 | -2.268 | -0.434 | -0.968 | -3.85 |
Free Cash Flow Per Share | -10.984 | -2.806 | -0.767 | -1.238 | -8.065 |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 3.44M | 9.71M | 20.69M | N/A | N/A |
Market Cap | 3.65M |
Price to Earnings Ratio | -0.27 |
Price to Sales Ratio | 0.64 |
Price to Cash Ratio | 0.28 |
Price to Book Ratio | 0.3 |
Dividend Yield | - |
Shares Outstanding | 10.01M |
Average Volume (1 week) | 4.64M |
Average Volume (1 Month) | 6.51M |
52 Week Change | -72.19% |
52 Week High | 2.27 |
52 Week Low | 0.2208 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.